These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15692073)

  • 21. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Finding optimal vaccination strategies for pandemic influenza using genetic algorithms.
    Patel R; Longini IM; Halloran ME
    J Theor Biol; 2005 May; 234(2):201-12. PubMed ID: 15757679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of influenza vaccine in non-high risk populations.
    Monto AS; Maassab HF
    Dev Biol Stand; 1977 Jun 1-3; 39():329-35. PubMed ID: 604116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public health. Who should get influenza vaccine when not all can?
    Emanuel EJ; Wertheimer A
    Science; 2006 May; 312(5775):854-5. PubMed ID: 16690847
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccination for pandemic influenza: a six point agenda for interpandemic years.
    Fedson DS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S74-7. PubMed ID: 14730273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(33):913-8. PubMed ID: 19713879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herd protection against influenza.
    Glezen WP
    J Clin Virol; 2006 Dec; 37(4):237-43. PubMed ID: 17008123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent changes in influenza vaccination recommendations, 2007.
    Zimmerman RK
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S12-7, C1. PubMed ID: 17270107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pandemic influenza and the global vaccine supply.
    Fedson DS
    Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccination coverage among children aged 6-59 months--eight immunization information system sentinel sites, United States, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1043-6. PubMed ID: 18818584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State-specific influenza vaccination coverage among adults aged > or =18 years--United States, 2003-04 and 2005-06 influenza seasons.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):953-9. PubMed ID: 17882124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccine coverage in paediatric population from central Israel.
    Stein M; Yossepowitch O; Somekh E
    J Infect; 2005 Jun; 50(5):382-5. PubMed ID: 15907544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004.
    Shuler CM; Iwamoto M; Bridges CB; Marin M; Neeman R; Gargiullo P; Yoder TA; Keyserling HL; Terebuh PD
    Pediatrics; 2007 Mar; 119(3):e587-95. PubMed ID: 17332179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.
    Szucs TD; Müller D
    Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza in the older adult. Indications for the use of vaccine and antiviral therapy.
    Sandhu SK; Mossad SB
    Geriatrics; 2001 Jan; 56(1):43-4, 47-8, 51. PubMed ID: 11196338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccination levels among persons aged > or =65 years and among persons aged 18-64 years with high-risk conditions--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Oct; 54(41):1045-9. PubMed ID: 16237375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intent to receive influenza A (H1N1) 2009 monovalent and seasonal influenza vaccines - two counties, North Carolina, August 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(50):1401-5. PubMed ID: 20032923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza vaccine. Past and present.
    Morgan R; O'Donnell C; Bresnitz E
    N J Med; 2001 Oct; 98(10):27-34. PubMed ID: 11695047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.